Millennium Management’s Amedisys AMED Stock Holding History

Millennium Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,300	Closed	-$1.57M	–	5918
2024 Q3	$1.57M	Hold	16,300	–	–	﹤0.01%	3920
2024 Q2	$1.5M	Hold	16,300	–	–	﹤0.01%	3781
2024 Q1	$1.5M	Hold	16,300	–	–	﹤0.01%	3974
2023 Q4	$1.55M	Hold	16,300	–	–	﹤0.01%	3812
2023 Q3	$1.52M	Sell	16,300 -73,600	-82%	-$6.8M	﹤0.01%	3825
2023 Q2	$8.22M	Buy	+89,900	New	+$7.38M	﹤0.01%	2211
2021 Q2	–	Sell	-5,000	Closed	-$1.32M	–	6478
2021 Q1	$1.32M	Buy	+5,000	New	+$1.41M	﹤0.01%	3923
2019 Q2	–	Sell	-10,000	Closed	-$1.23M	–	4016
2019 Q1	$1.23M	Buy	+10,000	New	+$1.26M	﹤0.01%	2737
2018 Q3	–	Sell	-40,000	Closed	-$3.42M	–	3862
2018 Q2	$3.42M	Buy	+40,000	New	+$2.94M	﹤0.01%	2050
2015 Q3	–	Sell	-100,000	Closed	-$3.97M	–	3428
2015 Q2	$3.97M	Buy	+100,000	New	+$3.12M	0.01%	1530

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's AMED Position: Q3 2025 in Review

Millennium Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 441,684 shares — an estimated $43.5M sold.

Millennium Management first reported a position in AMED in Q3 2013 and held it in 47 quarters. The position peaked at $113M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Millennium Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Millennium Management sold 441,684 Amedisys shares in Q3 2025, an estimated $43.5M.
Millennium Management first reported a position in Amedisys in Q3 2013 and held it in 47 quarters.
Millennium Management's Amedisys position peaked at $113M in Q4 2023.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.